A recent Npj Vaccines study discussed the success and challenges of developing different tuberculosis (TB) vaccine types.

Scientists reported that tuberculosis (TB) is one the foremost causes of global mortality, especially in adults. In 2019, around 10 million TB cases were reported, many of which were identified to be resistant to multiple drugs.